Reduction in doxorubicin toxicity following liposomal delivery.
Sells
R A
RA
Department of Surgery, Royal Liverpool Hospital, U.K.
Gilmore
I T
IT
Owen
R R
RR
New
R R
RR
Stringer
R E
RE
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D003110:Colonic Neoplasms / Q000188:drug therapy; D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D013274:Stomach Neoplasms / Q000188:drug therapy
D008081:Liposomes; D004317:Doxorubicin